0001104659-19-047352.txt : 20190826 0001104659-19-047352.hdr.sgml : 20190826 20190826214919 ACCESSION NUMBER: 0001104659-19-047352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190822 FILED AS OF DATE: 20190826 DATE AS OF CHANGE: 20190826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lavino Francesco Maria CENTRAL INDEX KEY: 0001711517 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 191054167 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 a4.xml 4 X0306 4 2019-08-22 0 0001641640 Nabriva Therapeutics plc NBRV 0001711517 Lavino Francesco Maria 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 Chief Commercial Officer Ordinary Shares 2019-08-22 4 P 0 4800 2.0375 A 15972 D The reporting person's purchase of ordinary shares of Nabriva Therapeutics plc (the "Issuer") reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 4,800 shares, with the reporting person's sale of 3,797 ordinary shares at a price of $2.08 per share on August 21, 2019. The reporting person has agreed to pay to the Issuer $204, representing the full amount of the profit realized in connection with the short-swing transaction. /s/ Robert Crotty, by power of attorney 2019-08-26